AXA Has Eliminated the Dilutive Impacts of Its 2014 and 2017 Convertible Bonds
2007年1月12日 - 4:25PM
PRニュース・ワイアー (英語)
PARIS, Jan. 12 /PRNewswire-FirstCall/ -- On January 11, 2007, the
meetings of holders of AXA's 2014 (ISIN: FR0000492076) and 2017
(ISIN: FR0000180994) convertible bonds were held to vote on an
amendment of the final conversion dates of the bonds to January 26,
2007 in exchange for a cash payment in respect of the value of the
conversion option. The meeting of holders of the 2014 convertible
bonds approved the amendment. Consequently, they may convert their
bonds into AXA shares up to and including January 26, 2007 (12:00
noon, CET) following which the bonds will no longer be convertible.
Any holders who have not converted by this date will receive Euro
16.23 per bond on January 31, 2007. The meeting of holders of the
2017 convertible bonds did not approve the amendment. Consequently,
AXA has put in place a hedge that offsets any dilutive impacts of
the 2017 convertible bonds, for a total cash amount equivalent to
the payment proposed to bondholders. For AXA shareholders, the
result of these transactions is to eliminate the potential dilutive
impact of the 2014 and 2017 convertible bonds (i.e. a maximum of
65.8 million shares). The total cash consideration to be paid by
AXA amounts to Euro 245 million. Overall, these operations are
expected to result in an accretion of fully diluted underlying
earnings per share of more than 1% from 2007. About AXA: AXA Group
is a worldwide leader in Financial Protection. AXA's operations are
diverse geographically, with major operations in Western Europe,
North America and the Asia/Pacific area. IFRS revenues amounted to
Euro 72 billion for full year 2005 and Euro 59 billion in 9M06. The
AXA ordinary share is listed and trades under the symbol AXA on the
Paris Stock Exchange. The AXA American Depository Share is also
listed on the NYSE under the ticker symbol AXA. AXA Investor
Relations: Etienne Bouas-Laurent: +33.1.40.75.57 25 Sophie
Bourlanges: +33.1.40.75.56.07 Emmanuel Touzeau: +33.1.40.75.49.05
Kevin Molloy: +1.212.314.2893 AXA Media Relations: Christophe
Dufraux: +33.1.40.75.46.74 Clara Rodrigo: +33.1.40.75.47.22 Armelle
Vercken: +33 1.40.75.46.42 Mary Taylor: +1.212.314.5845 IMPORTANT
LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-
LOOKING STATEMENTS Certain statements contained herein are
forward-looking statements including, but not limited to,
statements that are predications of or indicate future events,
trends, plans or objectives. Undue reliance should not be placed on
such statements because, by their nature, they are subject to known
and unknown risks and uncertainties. Please refer to AXA's Annual
Report on Form 20-F and AXA's Document de Reference for the year
ended December 31, 2005, for a description of certain important
factors, risks and uncertainties that may affect AXA's business.
AXA undertakes no obligation to publicly update or revise any of
these forward- looking statements, whether to reflect new
information, future events or circumstances or otherwise. The AXA
securities described in this press release have not and will not be
registered under U.S. securities laws, or the securities laws of
any other jurisdiction and may not be offered or sold in the United
States absent registration or an applicable exemption from
registration requirements. This press release is not an offer for
sale within the United States of any security of AXA or any of its
affiliates. This press release is being issued pursuant to and in
accordance with Rule 135c under the U.S. Securities Act of 1933, as
amended. DATASOURCE: AXA Group CONTACT: AXA Investor Relations:
Etienne Bouas-Laurent, +33.1.40.75.57 25, Sophie Bourlanges,
+33.1.40.75.56.07, Emmanuel Touzeau, +33.1.40.75.49.05, Kevin
Molloy, +1.212.314.2893; or AXA Media Relations: Christophe
Dufraux, +33.1.40.75.46.74, Clara Rodrigo, +33.1.40.75.47.22,
Armelle Vercken, +33 1.40.75.46.42, Mary Taylor, +1.212.314.5845
Web site: http://www.axa.com/
Copyright